Title: Hypercholesterolemia - Pipeline Review, H2 2015
1Hypercholesterolemia - Pipeline Review, H2 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE 1 (503) 894-6022E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2 Report Overview
- Scope
- The report provides a snapshot of the global
therapeutic landscape of Hypercholesterolemia - The report reviews key pipeline products under
drug profile section which includes, product
description, MoA and RD brief, licensing and
collaboration details other developmental
activities - The report reviews key players involved in the
therapeutics development for Hypercholesterolemia
and enlists all their major and minor projects - The report summarizes all the dormant and
discontinued pipeline projects - A review of the Hypercholesterolemia products
under development by companies and
universities/research institutes based on
information derived from company and
industry-specific sources - Pipeline products coverage based on various
stages of development ranging from
pre-registration till discovery and undisclosed
stages - A detailed assessment of monotherapy and
combination therapy pipeline projects - Coverage of the Hypercholesterolemia pipeline on
the basis of target, MoA, route of administration
and molecule type - Latest news and deals relating related to
pipeline products - Read More At http//www.researchbeam.com/hypercho
lesterolemia-pipeline-review-h2-2015-market
3 Table of Content
List Of FiguresNumber of Products under
Development for Hypercholesterolemia, H2 2015
15Number of Products under Development for
Hypercholesterolemia - Comparative Analysis, H2
2015 16Number of Products under Development by
Companies, H2 2015 17Number of Products under
Investigation by Universities/Institutes, H2 2015
21Comparative Analysis by Late Stage
Development, H2 2015 22Comparative Analysis by
Clinical Stage Development, H2 2015
23Comparative Analysis by Early Stage Products,
H2 2015 24Comparative Analysis by Unknown Stage
Development, H2 2015 25Assessment by Monotherapy
Products, H2 2015 65Assessment by Combination
Products, H2 2015 66Number of Products by Top 10
Targets, H2 2015 67Number of Products by Stage
and Top 10 Targets, H2 2015 67Number of Products
by Top 10 Mechanism of Actions, H2 2015 70Number
of Products by Stage and Top 10 Mechanism of
Actions, H2 2015 70Number of Products by Top 10
Routes of Administration, H2 2015 73Number of
Products by Stage and Top 10 Routes of
Administration, H2 2015 73Number of Products by
Top 10 Molecule Types, H2 2015 75Number of
Products by Stage and Top 10 Molecule Types, H2
2015 75
4 Table of Content
Reasons to buy Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD development
strategies Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage Develop strategic initiatives by
understanding the focus areas of leading
companies Identify and understand important and
diverse types of therapeutics under development
for Hypercholesterolemia Plan mergers and
acquisitions effectively by identifying key
players of the most promising pipeline Devise
corrective measures for pipeline projects by
understanding Hypercholesterolemia pipeline depth
and focus of Indication therapeutics Develop and
design in-licensing and out-licensing strategies
by identifying prospective partners with the most
attractive projects to enhance and expand
business potential and Scope Modify the
therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove
them from pipeline Enquire At
http//www.researchbeam.com/hypercholesterolemia-p
ipeline-review-h2-2015-market/enquire-about-report
5 FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/hypercholesterolemia-p
ipeline-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE 1 (800) 910-6452 DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com